Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities
Izabela Tuleta, Nikolaos G. Frangogiannis
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113904-113904
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
Zhennan Yuan, Yingpu Li, Sifan Zhang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 362
Transforming growth factor-β in myocardial disease
Nikolaos G. Frangogiannis
Nature Reviews Cardiology (2022) Vol. 19, Iss. 7, pp. 435-455
Closed Access | Times Cited: 192
Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation
Samar A. Antar, Nada A. Ashour, Mohamed E. Marawan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4004-4004
Open Access | Times Cited: 127
Fibroblasts: Immunomodulatory factors in refractory diabetic wound healing
Ye Liu, Yiqiu Liu, Wenjie He, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 93
Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions
Jin-Ling Huo, Qi Feng, Shaokang Pan, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 61
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 46
Stress hyperglycemia ratio as a prognostic indicator for long-term adverse outcomes in heart failure with preserved ejection fraction
Abdul‐Quddus Mohammed, Yongqiang Luo, Kaitao Wang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies
Susana Ravassa, Begoña López, Thomas A. Treibel, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101194-101194
Open Access | Times Cited: 38
NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways
Linlin Meng, Yue Lu, Xinlu Wang, et al.
Science Advances (2023) Vol. 9, Iss. 31
Open Access | Times Cited: 35
Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
Yanan Cheng, Yan Wang, Ruili Yin, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
Signaling Pathways and Potential Therapeutic Strategies in Cardiac Fibrosis
Alexandrine Foucault‐Bertaud, Ahmad Joshkon, Xavier Heim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1756-1756
Open Access | Times Cited: 24
Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis
Shujin Wang, Yinying Han, Ruimin Liu, et al.
Circulation Research (2024) Vol. 134, Iss. 5, pp. 505-525
Open Access | Times Cited: 12
Association of the triglyceride–glucose index with all-cause and cause-specific mortality: a population-based cohort study of 3.5 million adults in China
Guangda He, Zenglei Zhang, Chunqi Wang, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 49, pp. 101135-101135
Open Access | Times Cited: 9
Chronic Obstructive Pulmonary Disease and Type 2 Diabetes Mellitus: Complex Interactions and Clinical Implications
Lucreția Anghel, Anamaria Ciubară, Diana Pătraș, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1809-1809
Open Access | Times Cited: 1
TGF-β as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities
Nikolaos G. Frangogiannis
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 1-2, pp. 45-56
Closed Access | Times Cited: 7
Single-cell insights: pioneering an integrated atlas of chromatin accessibility and transcriptomic landscapes in diabetic cardiomyopathy
Qiang Su, Wanzhong Huang, Yu‐An Huang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease
Michael Weyrich, Sebastian Cremer, Martin Gerster, et al.
Circulation (2024) Vol. 150, Iss. 10, pp. 746-757
Open Access | Times Cited: 6
Fibroblast-specific TGF-β signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice
Izabela Tuleta, Anis Hanna, Claudio Humeres, et al.
Cardiovascular Research (2024)
Closed Access | Times Cited: 6
The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy
Siarhei A. Dabravolski, Nikolay K. Sadykhov, Andrey G. Kartuesov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7863-7863
Open Access | Times Cited: 23
Engeletin mediates antiarrhythmic effects in mice with isoproterenol-induced cardiac remodeling
Zhao Fang, Zhebo Liu, Tao Bo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114439-114439
Open Access | Times Cited: 15
An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis
Dóra Balogh, László Wagner, Andrea Fekete
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7789-7789
Open Access | Times Cited: 15
Novel approaches to target fibroblast mechanotransduction in fibroproliferative diseases
Maya Ezzo, Boris Hinz
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108528-108528
Closed Access | Times Cited: 13
WTAP boosts lipid oxidation and induces diabetic cardiac fibrosis by enhancing AR methylation
Kai Song, He Sun, Bin Tu, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107931-107931
Open Access | Times Cited: 13
Evaluation of the relationship between left atrial stiffness, left ventricular stiffness, and left atrioventricular coupling index in type 2 diabetes patients: a speckle tracking echocardiography study
Hai Nguyen Ngoc Dang, Thang Viet Luong, Binh Anh Ho
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 5
ERK1/2 Inhibition Alleviates Diabetic Cardiomyopathy by Suppressing Fatty Acid Metabolism
Erin McLean, Chloë De Roo, Annabel Maag, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top